Logo

Illumina Passes Antitrust Hurdle to Acquire Solexa

Dec 21, 2006
NEW YORK (GenomeWeb News) — Illumina today said it has received clearance under Hart-Scott-Rodino Antitrust regulations to continue with its proposed acquisition of Solexa.
 
The companies yesterday said Solexa and Illumina shareholders will vote on aspects of the acquisition on Jan. 26, 2007.

Filed under

Clinical Sequencing
Sequencing
Breaking News
The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.